Blood Research · 2014 · 13 citations · 5 references
MedicineHematologyOncologyCytogeneticsHematologic OncologyHematopathologyClinical HematologyHematologic DisordersHematologic MalignanciesHematopoietic NeoplasmsMolecular CytogeneticsMyeloproliferative NeoplasmsBcr-abl1 Fusion GeneClinical Genetic DiagnosisCytogenetics In Hematologic DiseaseLeukemia CytogeneticsMyeloid NeoplasmsMyeloproliferative Neoplasm TherapyMyeloproliferative Neoplasm TreatmentWhite Blood Cell Morphology
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by overproduction of myeloid white blood cells. Philadelphia chromosome is an essential finding for CML diagnosis. Generally, a clinical diagnosis of essential thrombocythemia (ET) can be established from isolated marked thrombocytosis in peripheral blood. However, Philadelphia chromosome-positivity or bcr/abl rearrangement with isolated thrombocytosis should be diagnosed as CML, not ET, according to World Health Organization diagnostic criteria. Therefore, CML should not be excluded before confirming the presence of the Philadelphia chromosome or bcr/abl rearrangement in cases of isolated thrombocytosis in peripheral blood. We report a case of CML with clinical features of ET in a patient successfully treated with imatinib.
5
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Hematology, Oncology +13
Ayalew Tefferi, Jüergen Thiele, Attilio Orazi et al. · Blood · 2007 · 858 citations · Full text
Essential thrombocythemia with BCR/ABL rearrangement
Yok‐Lam Kwong, E. K. W. Chiu, Raymond Liang et al. · Cancer Genetics and Cytogenetics · 1996 · 34 citations